These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2387329)

  • 1. Retention of vital dyes correlates inversely with the multidrug-resistant phenotype of adriamycin-selected murine fibrosarcoma variants.
    Bucana CD; Giavazzi R; Nayar R; O'Brian CA; Seid C; Earnest LE; Fan D
    Exp Cell Res; 1990 Sep; 190(1):69-75. PubMed ID: 2387329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transient enhancement of multidrug resistance by the bile acid deoxycholate in murine fibrosarcoma cells in vitro.
    O'Brian CA; Fan D; Ward NE; Dong Z; Iwamoto L; Gupta KP; Earnest LE; Fidler IJ
    Biochem Pharmacol; 1991 Mar; 41(5):797-806. PubMed ID: 1998534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct patterns of phorbol ester-induced downregulation of protein kinase C activity in adriamycin-selected multidrug resistant and parental murine fibrosarcoma cells.
    Ward NE; O'Brian CA
    Cancer Lett; 1991 Jul; 58(3):189-93. PubMed ID: 1855195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metastatic behavior of an adriamycin-resistant murine tumor.
    Giavazzi R; Miller L; Hart IR
    Cancer Res; 1983 Nov; 43(11):5081-6. PubMed ID: 6616446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved cellular accumulation is characteristic of anthracyclines which retain high activity in multidrug resistant cell lines, alone or in combination with verapamil or cyclosporin A.
    Coley HM; Twentyman PR; Workman P
    Biochem Pharmacol; 1989 Dec; 38(24):4467-75. PubMed ID: 2604747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of tumor growth inhibitory activity of macrophages exposed to adriamycin and adriamycin sensitivity of the target tumor cells.
    Giavazzi R; Bucana CD; Hart IR
    J Natl Cancer Inst; 1984 Aug; 73(2):447-55. PubMed ID: 6589436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of resistance to rhodamine 123 in adriamycin-resistant Friend leukemia cells.
    Lampidis TJ; Munck JN; Krishan A; Tapiero H
    Cancer Res; 1985 Jun; 45(6):2626-31. PubMed ID: 3986800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-resistance to rhodamine 123 in Adriamycin- and daunorubicin-resistant Friend leukemia cell variants.
    Tapiero H; Munck JN; Fourcade A; Lampidis TJ
    Cancer Res; 1984 Dec; 44(12 Pt 1):5544-9. PubMed ID: 6498816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of intrinsic resistance to adriamycin in normal cells by verapamil.
    Lampidis TJ; Krishan A; Planas L; Tapiero H
    Cancer Drug Deliv; 1986; 3(4):251-9. PubMed ID: 3567846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel N-myristylated synthetic octapeptide inhibits protein kinase C activity and partially reverses murine fibrosarcoma cell resistance to adriamycin.
    O'Brian CA; Ward NE; Liskamp RM; de Bont DB; Earnest LE; van Boom JH; Fan D
    Invest New Drugs; 1991 May; 9(2):169-79. PubMed ID: 1874600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of anthracyclines and related agents that retain preferential activity over adriamycin in multidrug-resistant cell lines, and further resistance modification by verapamil and cyclosporin A.
    Coley HM; Twentyman PR; Workman P
    Cancer Chemother Pharmacol; 1989; 24(5):284-90. PubMed ID: 2547527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rhodamine 123: is it an appropriate dye to study P-glycoprotein activity in adriamycin-resistant K562 cells?
    Denis-Gay M; Petit JM; Ratinaud MH
    Anticancer Res; 1995; 15(1):121-6. PubMed ID: 7733620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Membrane potential differences between adriamycin-sensitive and -resistant cells as measured by flow cytometry.
    Hasmann M; Valet GK; Tapiero H; Trevorrow K; Lampidis T
    Biochem Pharmacol; 1989 Jan; 38(2):305-12. PubMed ID: 2914014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular pharmacology of MX2, a new morpholino anthracycline, in human pleiotropic drug-resistant cells.
    Watanabe M; Komeshima N; Naito M; Isoe T; Otake N; Tsuruo T
    Cancer Res; 1991 Jan; 51(1):157-61. PubMed ID: 1988080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Level of protein kinase C activity correlates directly with resistance to adriamycin in murine fibrosarcoma cells.
    O'Brian CA; Fan D; Ward NE; Seid C; Fidler IJ
    FEBS Lett; 1989 Mar; 246(1-2):78-82. PubMed ID: 2707442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Competitive inhibition by verapamil of ATP-dependent high affinity vincristine binding to the plasma membrane of multidrug-resistant K562 cells without calcium ion involvement.
    Naito M; Tsuruo T
    Cancer Res; 1989 Mar; 49(6):1452-5. PubMed ID: 2924298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of multidrug-resistant pituitary tumor cells.
    Nelson EJ; Hinkle PM
    Endocrinology; 1992 Jun; 130(6):3246-56. PubMed ID: 1350759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of vincristine- and adriamycin-induced cytotoxicity by verapamil in P388 leukemia and its sublines resistant to vincristine and adriamycin.
    Tsuruo T; Iida H; Yamashiro M; Tsukagoshi S; Sakurai Y
    Biochem Pharmacol; 1982 Oct; 31(19):3138-40. PubMed ID: 7150340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation and preliminary characterization of an Adriamycin-resistant murine fibrosarcoma cell line.
    Giavazzi R; Scholar E; Hart IR
    Cancer Res; 1983 May; 43(5):2216-22. PubMed ID: 6831444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of murine tumor cell sensitivity to adriamycin by presentation of the drug in phosphatidylcholine-phosphatidylserine liposomes.
    Fan D; Bucana CD; O'Brian CA; Zwelling LA; Seid C; Fidler IJ
    Cancer Res; 1990 Jun; 50(12):3619-26. PubMed ID: 2340511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.